Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06742073 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Histiocytosis and Inflammatory Manifestations in Patients with H Syndrome

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 19, 2024 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
H syndrome is a rare genetic disorder predisposing to histiocytosis. Our knowledge of the clinical spectrum of these patients is based on case reports and small patient series. Patients with H syndrome have been treated with a range of immunomodulatory and chemotherapeutic agents, with limited success. We aim to comprehensively assess the clinical manifestations and patterns of treatment response in a multinational cohort of patients with H syndrome.
Trial Details
NCT Number NCT06742073
Lead Sponsor Rabin Medical Center
Conditions
(from sponsor)		 H Syndrome
Related terms Histiocytosis with joint contractures and sensorineural deafness
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov